MEETINGS - Seminar on The Drug and Device Interface (UK) April 1996:
This article was originally published in Clinica
A one-day seminar on The Drug/Device Interface will take place on April 15th, 1996, in London, UK. This introduction to the EU legislation offers an overview of current issues in the medical device and pharmaceutical industries. Further information is available from: Management Forum, 48 Woodbridge Road, Guildford, Surrey GU1 4RJ, UK. Tel: +44 (1483) 570099. Fax: +44 (1483) 36424.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.